Press release content from Business Wire. The AP news staff was not involved in its creation.
DiaMedica Therapeutics Provides a Business Update and Announces First Quarter 2021 Financial Results
May 5, 2021 GMT
MINNEAPOLIS--(BUSINESS WIRE)--May 5, 2021--
DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and kidney diseases, today provided a business update and financial results for the quarter ended March 31, 2021. DiaMedica will host a conference call Thursday, May 6, 2021, at 7:00 a.m. Central Time to discuss its business update and first quarter financial results.
Clinical Developments
IND Submitted
Initiation of Phase 2/3 Trial of DM199 in AIS in Summer 2021